MARKET

LENZ

LENZ

LENZ THERAPEUTICS INC
NASDAQ
4.790
-0.250
-4.96%
Opening 12:19 08/13 EDT
OPEN
5.02
PREV CLOSE
5.04
HIGH
5.25
LOW
4.745
VOLUME
587.47K
TURNOVER
--
52 WEEK HIGH
50.40
52 WEEK LOW
4.680
MARKET CAP
150.50M
P/E (TTM)
-1.3328
1D
5D
1M
3M
1Y
5Y
1D
LENZ Therapeutics (LENZ) Stock Reflects Loss Fatigue Despite Long Cash Runway
Simply Wall St · 17h ago
LENZ Therapeutics Price Target Cut to $7.00/Share From $12.00 by Piper Sandler
Dow Jones · 1d ago
LENZ Therapeutics Is Maintained at Neutral by Piper Sandler
Dow Jones · 1d ago
Piper Sandler Maintains Neutral on LENZ Therapeutics, Lowers Price Target to $7
Benzinga · 1d ago
Analyst Maintains Buy on LENZ as VIZZ Adoption, Prescriber Engagement and Patient Refill Trends Support Long-Term Commercial Franchise Growth
TipRanks · 1d ago
At a glance: stocks gapping up premarket
Seeking Alpha · 1d ago
Piper Sandler Sticks to Its Hold Rating for LENZ Therapeutics (LENZ)
TipRanks · 1d ago
Analyst Maintains Buy on LENZ, Cuts VIZZ Price Target to $10 While Highlighting Strong Patient Persistence and Long-Term Upside
TipRanks · 1d ago
More
About LENZ
LENZ Therapeutics, Inc. is a pre-commercial stage biopharmaceutical company. The Company is focused on the development and commercialization of aceclidine-based eye drop to improve near vision in patients with presbyopia. The Company’s lead product candidate LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine. LNZ100 was evaluated in the registration-enabling Phase III CLARITY study as a potential therapy for the treatment of presbyopia, a condition impacting over 1.8 billion people globally and 128 million people in the United States. Its other product LNZ101, is a preservative-free eye drop containing aceclidine and brimonidine.

Webull offers Lenz Therapeutics Inc stock information, including NASDAQ: LENZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LENZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LENZ stock methods without spending real money on the virtual paper trading platform.